ISLR2 activators comprise a range of chemical compounds that indirectly augment the functional activity of ISLR2 through diverse intracellular signaling pathways. Compounds such as Epinephrine, Forskolin, and Nicotinic acid modulate the levels of cAMP, a pivotal second messenger in cellular signaling. Epinephrine achieves this by stimulating adrenergic receptors, which can increase ISLR2 activity within cAMP-dependent signaling pathways. Forskolin, bypassing receptor engagement, directly activates adenylyl cyclase, resulting in raised cAMP concentrations and subsequent activation of PKA. This kinase has the potential to phosphorylate substrates that interact with ISLR2, thus enhancing its activity. Nicotinic acid, on the other hand, exerts its effects through the GPR109A receptor, indirectly influencingISLR2 signaling network, leading to an enhancement of ISLR2's functional parameters. Similarly, IBMX, by inhibiting the degradation of cAMP, and ATP, through its action on purinergic receptors, elevate cAMP or calcium levels within the cell, further influencing the activity of ISLR2 through these secondary messengers. Histamine, Acetylcholine, and Adenosine each engage with their respective receptors to induce changes in intracellular calcium or cAMP, which can indirectly upregulate ISLR2's functional state. Histamine, for instance, activates phospholipase C, heightening intracellular calcium, a potent activator of numerous cellular processes that could intersect with ISLR2's role.
The array of ISLR2 activators also includes molecules like Nitric Oxide, which stimulates guanylate cyclase, and Serotonin, with its capacity to bind various receptors affecting cAMP, PKC, and MAPK pathways, all potentially conducive to enhanced ISLR2 activity. Glucagon, through its interaction with its cognate receptor, also raises cAMP levels, further potentiating the ISLR2 signaling cascade via PKA activation. Lastly, Angiotensin II, by engaging with G-protein coupled receptors, activates multiple downstream signaling molecules like PLC, PKC, and MAPK, suggesting a broadened scope of modulation and potential amplification of ISLR2's functional activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine interacts with adrenergic receptors, which in turn can lead to the activation of secondary messenger pathways such as cAMP. The increase in cAMP levels can enhance the functional activity of ISLR2 by promoting intracellular signaling cascades that ISLR2 is involved in, especially if ISLR2 is part of the cAMP-dependent pathway. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly stimulates adenylyl cyclase, thereby increasing the levels of cAMP within the cell. Elevated cAMP can activate protein kinase A (PKA), which may phosphorylate target proteins that interact with or regulate ISLR2, thereby enhancing ISLR2's functional activity. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX, or 3-Isobutyl-1-methylxanthine, is a nonspecific inhibitor of phosphodiesterases, enzymes that degrade cAMP and cGMP. By preventing the breakdown of cAMP, IBMX can indirectly lead to the activation of signaling pathways that include ISLR2, enhancing its activity. | ||||||
Nicotinic Acid | 59-67-6 | sc-205768 sc-205768A | 250 g 500 g | $62.00 $124.00 | 1 | |
Nicotinic acid binds to G-protein coupled receptors, specifically the GPR109A receptor, which can lead to the inhibition of adenylate cyclase and subsequent modulation of cAMP levels. This modulation can indirectly affect the signaling pathways involving ISLR2, leading to its enhanced activity. | ||||||
Histamine, free base | 51-45-6 | sc-204000 sc-204000A sc-204000B | 1 g 5 g 25 g | $94.00 $283.00 $988.00 | 7 | |
Histamine interacts with its receptors, which can activate phospholipase C, leading to increased intracellular calcium levels. Calcium signaling is important in many cellular processes and could enhance the functional activity of ISLR2 through calcium-dependent signaling pathways. | ||||||
Adenosine 5′-Triphosphate, disodium salt | 987-65-5 | sc-202040 sc-202040A | 1 g 5 g | $39.00 $75.00 | 9 | |
ATP can act on purinergic receptors leading to increased calcium influx or cAMP production. These secondary messengers can enhance ISLR2 activity by influencing the signaling pathways ISLR2 is associated with. | ||||||
Adenosine | 58-61-7 | sc-291838 sc-291838A sc-291838B sc-291838C sc-291838D sc-291838E sc-291838F | 1 g 5 g 100 g 250 g 1 kg 5 kg 10 kg | $34.00 $48.00 $300.00 $572.00 $1040.00 $2601.00 $4682.00 | 1 | |
Adenosine acts on its G-protein coupled receptors leading to varied intracellular effects including modulation of cAMP levels. By influencing cAMP, adenosine may enhance signaling pathways that involve ISLR2, leading to its increased activity. | ||||||
3-(2-Aminoethyl)-1H-indol-5-ol | 50-67-9 | sc-298707 | 1 g | $530.00 | 3 | |
Serotonin can interact with its wide range of receptors to activate various signaling pathways including those involving cAMP, PKC, and MAPK, all of which may potentially enhance the activity of ISLR2. | ||||||
Angiotensin II, Human | 4474-91-3 | sc-363643 sc-363643A sc-363643B sc-363643C | 1 mg 5 mg 25 mg 100 mg | $51.00 $100.00 $310.00 $690.00 | 3 | |
Angiotensin II binds to its G-protein coupled receptors and can lead to the activation of PLC, PKC, and MAPK signaling pathways. These pathways can enhance the functional activity of ISLR2 by modulating the cellular processes that ISLR2 is involved in. | ||||||